Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06218914
Title A Study of NT-112 in HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, and/ or Metastatic Solid Tumors Positive for the KRAS G12D Mutation
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Neogene Therapeutics, Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.